Baidu
map

Vaccine:2014-2015年迪士尼麻疹爆发教会了我们什么

2016-05-21 佚名 生物谷

近日,发表在《疫苗》杂志上的研究显示了一篇关于疫苗病毒的文章:疫苗接种的意义。David Broniatowski助教领导了这项研究。 这项研究的结果对在迪斯尼乐园麻疹疫情的新闻发布有关事情进行了分析。Broniatowski博士和他的同事们说,经过一段时间后重新讨论疫苗的安全性,这件事直接影响了记者、医生和公共卫生官员与病人和公众的沟通。 “当听到一则新闻或阅读原始统计数据后,读者可能会不明

近日,发表在《疫苗》杂志上的研究显示了一篇关于疫苗病毒的文章:疫苗接种的意义。David Broniatowski助教领导了这项研究。

这项研究的结果对在迪斯尼乐园麻疹疫情的新闻发布有关事情进行了分析。Broniatowski博士和他的同事们说,经过一段时间后重新讨论疫苗的安全性,这件事直接影响了记者、医生和公共卫生官员与病人和公众的沟通。

“当听到一则新闻或阅读原始统计数据后,读者可能会不明白这篇文章对他们意味着什么,而科学对疾病如麻疹和流感疫苗是最清楚的。”Broniatowski博士说。“有关重要消息的文章需要对病人解释数为什么。”

为了了解什么使一篇关于疫苗的文章传播的如此之快,研究人员分析了4000多篇新闻文章,内容有关2014-2015年美国迪斯尼乐园麻疹爆发,147人患病,评估什么使他们如粗快速的患病。

“很多人对疫苗产生兴趣后紧跟着迪斯尼乐园麻疹爆发创造了完美的环境来验证这些理论。”Mark Dredze说,“计算算法可让我们分析成千上万的文章和数以百万计的社交媒体新闻。”

Karen Hilyard说:“统计数据不会使病人信服,与病人沟通最有效的方式是让医生和公共卫生官员以一种有意义的方式帮助病人解释这些数据,帮助他们记住主要的东西。”

这项研究的结果支持“模糊痕迹理论,”这是一个心理学理论,它有两种类型的记忆:要点(最重要的重点)和逐项事情(事实、统计数据等),通信重点更加引人注意。

研究人员还发现,会表达积极的看法以及“抗疫苗”观点的文章比其他文章共享率高出58倍。这意味着如果人们承认文章的观点那么该文章更有可能被共享,同时对其他人还有重要意义。

原始出处

Broniatowski DA,Hilyard KM,Dredze M.Effective vaccine communication during the disneyland measles outbreak.Vaccine 2016 May 6

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1773548, encodeId=77341e73548b4, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Apr 30 03:14:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325241, encodeId=5e86132524137, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon May 23 13:14:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355557, encodeId=c1c2135555eb2, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon May 23 13:14:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86821, encodeId=3bda86821ad, content=如粗?是如此吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150715/IMG55A6458618E327245.jpg, createdBy=69501634546, createdName=皮肤小生, createdTime=Sun May 22 13:14:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86816, encodeId=3578868165c, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Sun May 22 11:20:00 CST 2016, time=2016-05-22, status=1, ipAttribution=)]
    2017-04-30 kalseyzl
  2. [GetPortalCommentsPageByObjectIdResponse(id=1773548, encodeId=77341e73548b4, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Apr 30 03:14:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325241, encodeId=5e86132524137, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon May 23 13:14:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355557, encodeId=c1c2135555eb2, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon May 23 13:14:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86821, encodeId=3bda86821ad, content=如粗?是如此吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150715/IMG55A6458618E327245.jpg, createdBy=69501634546, createdName=皮肤小生, createdTime=Sun May 22 13:14:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86816, encodeId=3578868165c, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Sun May 22 11:20:00 CST 2016, time=2016-05-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1773548, encodeId=77341e73548b4, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Apr 30 03:14:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325241, encodeId=5e86132524137, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon May 23 13:14:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355557, encodeId=c1c2135555eb2, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon May 23 13:14:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86821, encodeId=3bda86821ad, content=如粗?是如此吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150715/IMG55A6458618E327245.jpg, createdBy=69501634546, createdName=皮肤小生, createdTime=Sun May 22 13:14:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86816, encodeId=3578868165c, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Sun May 22 11:20:00 CST 2016, time=2016-05-22, status=1, ipAttribution=)]
    2016-05-23 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1773548, encodeId=77341e73548b4, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Apr 30 03:14:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325241, encodeId=5e86132524137, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon May 23 13:14:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355557, encodeId=c1c2135555eb2, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon May 23 13:14:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86821, encodeId=3bda86821ad, content=如粗?是如此吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150715/IMG55A6458618E327245.jpg, createdBy=69501634546, createdName=皮肤小生, createdTime=Sun May 22 13:14:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86816, encodeId=3578868165c, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Sun May 22 11:20:00 CST 2016, time=2016-05-22, status=1, ipAttribution=)]
    2016-05-22 皮肤小生

    如粗?是如此吧?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1773548, encodeId=77341e73548b4, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sun Apr 30 03:14:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325241, encodeId=5e86132524137, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon May 23 13:14:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355557, encodeId=c1c2135555eb2, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon May 23 13:14:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86821, encodeId=3bda86821ad, content=如粗?是如此吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150715/IMG55A6458618E327245.jpg, createdBy=69501634546, createdName=皮肤小生, createdTime=Sun May 22 13:14:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86816, encodeId=3578868165c, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Sun May 22 11:20:00 CST 2016, time=2016-05-22, status=1, ipAttribution=)]
    2016-05-22 lovejing

    0

相关资讯

奥巴马呼吁给孩子接种麻疹疫苗

美国麻疹疫情仍在扩散,据美国疾病控制和预防中心最新统计,今年1月美国已有超过100人感染麻疹,美国总统奥巴马呼吁家长带孩子去接种疫苗。 据美疾控中心本周发布的统计数字,今年1月1日至30日,美国加利福尼亚州和纽约州等14个州出现麻疹疫情,共有102人感染,这些病例中有许多人曾到加州的迪士尼乐园游玩。加州迪士尼乐园去年12月出现麻疹疫情,但其源头尚无法确定。 美国总统奥巴马日前在接受

PNAS:如何提高MMR疫苗接种率?宣教内容很重要

发表在《美国科学院论文集》的研究表明,加强人们对麻疹致病性的了解和对麻疹、腮腺炎和风疹(MMR)疫苗的了解,可以使家长为孩子积极接种疫苗以使孩子免受疾病的困扰;然而,家长若对疫苗对安全性产生担忧及不信任,则很可能导致家长不会为孩子接种疫苗。据CDC统计,去年麻疹爆发期间,79%的麻疹感染者是由于对MMR疫苗的安全性产生质疑进而导致患者拒绝接种疫苗引起的。“由于民众普遍对麻疹疫苗的安全性产生质疑,导

JAMA:美国拒绝接种疫苗的后果回顾

父母犹豫给儿童接种疫苗,可能会耽误常规的疫苗接种,或寻求免除接种国家疫苗方法。最近疫苗可预防的疾病在美国爆发引起了对这一现象的关注。提高对拒绝使用疫苗与这些疾病流行的关系的理解是有必要的。

麻疹来袭:哪些是你应该知道的?

近期,美国出现了麻疹疫情,17个州出现了121名麻疹病人。中国多个省份也报道了麻疹病例。美国疾病控制与预防中心(CDC)近日刊文介绍麻疹的一些基本常识。 麻疹是一种高传染性疾病,常见于儿童,会对儿童造成很大伤害。父母应当确保子女及时接种麻疹疫苗。麻疹的最初症状是发热。随后引起咳嗽、流鼻涕、眼睛发红。然后皮肤出现大量的红疹。麻疹很可能引起肺炎、脑炎,甚至死亡。 麻疹是如何传播的? 麻疹可

NEJM:雾化吸入麻疹疫苗也是有效

麻疹是儿童最常见的急性呼吸道传染病之一,其传染性很强,是造成疾病和死亡的原因之一。通过雾化吸入方式接种麻疹疫苗,可以免却传统皮下注射针刺之痛等伤害,但是目前临床上关于儿童雾化吸入麻疹疫苗对麻疹的免疫原性数据不一致。因此Low N等人进行了一项研究以探究雾化吸入麻疹疫苗的有效性和安全性。

NEJM:“麻疹”之旅

一名54的女士作为传教士访问菲律宾后返回美国,随即出现了发热、咳嗽和流鼻涕的症状,持续了5天之久。既往她没有显著的临床病史,不记得自己以往是否有患过麻疹病史。但是,她称在自己小的时候,曾经全面接受过疫苗接种,其中包括麻疹疫苗。但药物的剂量和浓度已不明确。经体格检查发现,她的头部、颈部和肩膀部(如图A所示)等部位均出现了全身弥漫性分布的麻疹。在颊部黏膜上可见有白色的小丘疹(图B所示)。此外,该女士还

Baidu
map
Baidu
map
Baidu
map